Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
ADC Therapeutics SA Common Shares
(NY:
ADCT
)
1.100
+0.010 (+0.92%)
Streaming Delayed Price
Updated: 3:47 PM EDT, Jun 22, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ADC Therapeutics SA Common Shares
< Previous
1
2
3
4
5
6
7
8
9
Next >
ADC Therapeutics Announces Validation of its Marketing Authorization Application by the European Medicines Agency for ZYNLONTA®
October 29, 2021
From
ADC Therapeutics SA
Via
Business Wire
ADC Therapeutics to Host Third Quarter 2021 Financial Results Conference Call on November 2, 2021
October 27, 2021
From
ADC Therapeutics SA
Via
Business Wire
Overland ADCT BioPharma Announces First Patient Dosed in China with ZYNLONTA® in Pivotal Phase 2 Clinical Trial for Diffuse Large B-cell Lymphoma
September 29, 2021
From
ADC Therapeutics
Via
Business Wire
ADC Therapeutics Doses First Patient in Phase 1 Clinical Trial of ADCT-901 in Advanced Solid Tumors
September 27, 2021
From
ADC Therapeutics SA
Via
Business Wire
ADC Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare Conference
September 23, 2021
From
ADC Therapeutics SA
Via
Business Wire
ADC Therapeutics Receives Orphan Drug Designation in Europe for ZYNLONTA®
September 13, 2021
From
ADC Therapeutics SA
Via
Business Wire
ADC Therapeutics to Participate in Morgan Stanley’s 19th Annual Global Healthcare Conference
September 09, 2021
From
ADC Therapeutics SA
Via
Business Wire
ADC Therapeutics Announces Medical Leadership Transition
September 03, 2021
From
ADC Therapeutics SA
Via
Business Wire
ADC Therapeutics Announces $325M Financing Agreement With HealthCare Royalty
↗
August 26, 2021
ADC Therapeutics SA (NYSE: ADCT) has entered into a royalty purchase agreement with HealthCare Royalty Partners for up to $325 million. ADC Therapeutics...
Via
Benzinga
ADC Therapeutics Enters Into a Financing Agreement with HealthCare Royalty for Up to $325 Million
August 26, 2021
From
ADC Therapeutics SA
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2021
↗
August 09, 2021
Upgrades DA Davidson upgraded the previous rating for AAON Inc (NASDAQ:
Via
Benzinga
ADC Therapeutics SA (ADCT) Q2 2021 Earnings Call Transcript
↗
August 03, 2021
ADCT earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
↗
August 03, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
ADC Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Updates
August 03, 2021
From
ADC Therapeutics SA
Via
Business Wire
ADC Therapeutics to Host Second Quarter 2021 Financial Results Conference Call on August 3, 2021
July 28, 2021
From
ADC Therapeutics SA
Via
Business Wire
ADC Therapeutics Announces Encouraging Interim Results from Pivotal Phase 2 Clinical Trial of Camidanlumab Tesirine (Cami) Presented at the 16th Annual International Conference on Malignant Lymphoma
June 22, 2021
From
ADC Therapeutics SA
Via
Business Wire
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
↗
August 01, 2021
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....
Via
Benzinga
ADC Therapeutics Presents Updated ZYNLONTA™ (loncastuximab tesirine-lpyl) Clinical Data at 16th Annual International Conference on Malignant Lymphoma
June 18, 2021
From
ADC Therapeutics SA
Via
Business Wire
Expert Ratings for ADC Therapeutics
↗
June 15, 2021
Within the last quarter, ADC Therapeutics (NYSE:ADCT) has observed the following analyst ratings: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 0 0 2 1...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2021
↗
June 15, 2021
Upgrades According to Raymond James, the prior rating for Welltower Inc (NYSE:WELL) was changed from Market Perform to Strong Buy. For the first quarter, Welltower had an...
Via
Benzinga
ADC Therapeutics Shareholders Approve All Resolutions at the Annual General Meeting
June 11, 2021
From
ADC Therapeutics SA
Via
Business Wire
ADC Therapeutics Announces Presentations at the 16th Annual International Conference on Malignant Lymphoma
June 09, 2021
From
ADC Therapeutics SA
Via
Business Wire
ADC Therapeutics Presents Updated Clinical Data at 2021 ASCO Annual Meeting
June 04, 2021
From
ADC Therapeutics SA
Via
Business Wire
ADC Therapeutics to Present at Jefferies Virtual Healthcare Conference
May 27, 2021
From
ADC Therapeutics SA
Via
Business Wire
The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes
↗
May 31, 2021
After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-...
Via
Benzinga
ADC Therapeutics Announces Online Publication of Camidanlumab Tesirine Phase 1 Results in The Lancet Haematology
May 26, 2021
From
ADC Therapeutics SA
Via
Business Wire
ADC Therapeutics Announces Presentations at the 2021 ASCO Annual Meeting
May 19, 2021
From
ADC Therapeutics SA
Via
Business Wire
ADC Therapeutics Announces Receipt of $50 Million Second Tranche of Convertible Credit Facility with Deerfield
May 17, 2021
From
ADC Therapeutics SA
Via
Business Wire
The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts
↗
May 14, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13) Alexion Pharmaceuticals, Inc...
Via
Benzinga
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
↗
May 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
